Exabis Library
Welcome to the e-CCO Library!
P507: Vulvar Crohn’s disease: A challenging diagnosis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P507: What is the impact of infliximab metaoptimisation on surgical rates and need-to-change-therapy in real-world practice for severe inflammatory bowel disease?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P508 Safety and efficacy of combining biological therapies together or with small molecules in patients with inflammatory bowel disease: A retrospective multicentre national observational case series study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P508: Association between clinical outcome and post induction CT-P13 trough levels at week 14, in patients with inflammatory bowel disease. Preliminary results in an observational multicentric study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P508: Does corticosteroid therapy affect prognosis in inflammatory bowel disease patients hospitalised with Clostridium difficile infection?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P508: Dose adjustment in patients with moderate to severe ulcerative colitis: results from year 3 of the UNIFI maintenance study long-term extension
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P508: Pregnancy outcomes in patients with inflammatory bowel disease experiencing flare ups during foetal development
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P508: Response of hepatitis B vaccination in patients with inflammatory bowel disease; prospective observational study in Korea
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P508: Sarcopenia is associated with increased rates of infectious post-operative complications in Crohn's disease patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P508: The impact of disease duration and early biologic treatment on transmural healing in Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P509 Vedolizumab levels in breast milk: Results from a prospective, postmarketing, milk-only lactation study in nursing mothers with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P509: Biomarkers of neutrophil activity and extracellular matrix turnover predict long-term response to vedolizumab in patients with Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P509: IBD cancer and serious infections in Europe (I-CARE): a European prospective observational study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P509: Influence of concomitant immunosuppresives in retention rate in Crohn´s Disease patients under ustekinumab in the SUSTAIN Study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P509: Long-term outcomes in biologic-treated perianal Crohn’s fistula
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P509: Long-term outcomes of adalimumab in patients with Crohn’s disease: Can a doubled dose of adalimumab improve outcomes?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P509: Surgery and biologic prescription rates for Crohn's disease in Lothian, Scotland; an updated population-based cohort study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P509: What is the effect of inflammatory bowel disease on sedation rates at colonoscopy?
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P510 Dose escalation of subcutaneous vedolizumab in patients with ulcerative colitis: A post hoc analysis of the VISIBLE trial data
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P510: Assessment of study group – patients with inflammatory bowel disease, treated with monoclonal anti-TNF alpha: a multicenter, prospective cohort observational study, Satimos – preliminary report in pediatric population
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM